Stay updated on Venetoclax in Myeloma with Bortezomib: Clinical Trial
Sign up to get notified when there's something new on the Venetoclax in Myeloma with Bortezomib: Clinical Trial page.

Latest updates to the Venetoclax in Myeloma with Bortezomib: Clinical Trial page
- Check4 days agoChange DetectedThe site footer now identifies the ClinicalTrials.gov release as v3.7.1 instead of v3.7.0.SummaryDifference0.1%

- Check11 days agoNo Change Detected
- Check18 days agoNo Change Detected
- Check25 days agoChange DetectedA new revision entry (v3.7.0) has been added to the study history and the previous revision (v3.6.6) has been removed, updating the record's version history.SummaryDifference0.1%

- Check82 days agoChange DetectedA new site revision tag 'Revision: v3.6.4' was added, replacing 'Revision: v3.6.3', indicating a minor system update to the page rendering.SummaryDifference0.1%

- Check103 days agoChange DetectedA new revision entry Revision: v3.6.3 was added and the old Revision: v3.6.1 was removed from the study record history. This updates the page's revision metadata without altering core content or functionality.SummaryDifference0.1%

- Check110 days agoChange DetectedA new revision stamp, v3.6.1, was added to the history, replacing the previous v3.6.0 entry. This reflects a newer version of the study record being published in the history log.SummaryDifference0.1%

- Check117 days agoChange DetectedAdded a note that recruitment is no longer open to participants, and the record now shows a new revision tag v3.6.0 while removing the previous v3.5.5 tag.SummaryDifference0.3%

Stay in the know with updates to Venetoclax in Myeloma with Bortezomib: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Venetoclax in Myeloma with Bortezomib: Clinical Trial page.